Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CIEN vs MRNA✓SelectedUSD · MRNACIEN vs MRNA performance historyLatest closeAs of-10.76%11/20
Stock and ETF performance explorer

CIEN vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+649.3%
MRNA return
+786.4%
Excess return
-137.1%
Maximum drawdown
-63.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.8%-2.2%-8.6%-10.6%
7D-16.5%-12.7%-3.8%-15.7%
30D-35.1%-20.7%-14.5%-34.2%
3M-40.3%+46.3%-86.5%-41.8%
6M-57.8%+305.2%-363.0%-64.3%
YTD+0.2%+561.2%-561.0%-20.3%
1Y+32.8%+772.1%-739.3%+2.6%
3Y+421.2%+147.0%+274.2%+339.4%
5Y+285.7%-26.1%+311.7%+245.3%
All+649.3%+786.4%-137.1%+463.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling